Introduction
The primary cause of cancer-related death is metastasis, which generally begins with misregulation of cell adhesion and migration of cancer cells away from the primary tumour. A key molecule in this process is the cell-adhesion molecule and tumour suppressor E-cadherin, which is often down-or misregulated in many cancer types. Inhibition of E-cadherin dynamics is associated with decreased cell migration, [1] thus suggesting that the development of cell migration inhibitors and gaining an understanding of their mode of action could help in the identification of new anticancer drugs. [3] Some of the simpler analogues (e.g. 4--6) have inhibited migration of highly metastatic tumour cells in mouse models. [4] Compound^^8 showed antibranching activity and interfered with the assembly of filopodia, thus preventing crosslinking of fascin1-dependent actin filaments in^^vitro. [5] It has been proposed that macroketone^^4 targets the actin bundling protein fascin1 and that this explains the observed effects on cell migration. [6] However, there is debate about the mechanism. Danishefsky and co-workers have suggested that an intracellular protein such fascin1 might not be the primary target. <? ><?>reference? (is this in [3] ?)<-please add this reference -N. Lecomte, J. T. Njardarson, P. Nagorny, G. Yang, R. Downey, O. Ouerfelli, M. A. Moore, S. J. Danishefsky, Proc. Natl. Acadl. Sci. USA 2011 , 108, 15074-1507 Other changes suggested to figure 1 ?><?> Compound^^7, which was a potent inhibitor of metastasis in an in^^vivo lung cancer model, bears a carboxylic acid, which would be expected to reduce permeability of the small molecule through the cell membrane and lead to a reduction in activity.
<?><?>reference for the in vivo lung cancer model paper? (is this in [3] ? )<?><?>However this was not the case and led these researchers to propose that the primary target could be a receptor at the cell surface rather than one inside the cell.
A number of different preparations of migrastatin [3,^7] and its core (2) [8] have been reported, as well as the semisynthesis from isomigrastatin (a precursor generated by fermentation).
[9] The truncated migrastatin analogues 2--7 and other such compounds have been prepared by chemical synthesis. [3] Published syntheses have shown that 1--7 can be obtained via alcohol^^16 (Scheme^^1<schr1> including 4 on a 100^^mg scale. The effects of 4 on E-cadherin dynamics were studied in^^vitro and in^^vivo; these indicated a possible mechanism by which 4 inhibits metastasis.
Synthesis of macroketone and migrastatin
In fragment^^16 there are three chiral centres, a terminal olefin and an allylic alcohol with an alkene that has Z-configuration (Scheme^^1<xschr1>). The Z configuration at C2,3
can be prepared by olefination by using Ando's phosphonate ester. [7b--c,^10] Change references here to [8, 10] It was envisaged that the stereocentres at C5,6 could potentially be installed by using diastereoselective Brown alkoxyallylation [11] from the allyl methyl ether^^9 and the chiral aldehyde^^10 (the latter as prepared by Trost et al.) . [12] The synthesis began with a scale-up of the method of Trost et al.; hence, the highly diastereoselective addition of [(Z)-γ-methoxyallyl]diisopinocampheylborane to aldehyde^^10 gave 11 after work-up.
Subsequent cleavage of the benzoate protecting group [13] afforded diol^^12 (~4^^g) as a single diastereoisomer in 73^% yield from 10. Protection of both alcohol groups of 12 as TBS ethers and subsequent regioselective cleavage of the TBS group were achieved by using a catalytic quantity of tosic acid in methanol to give the primary alcohol^^13. Dess--Martin [2,^6a,^7b] or its precursor or analogues.
[ 6b--c,^7b] Change Ref [2,6a,7b] with Ref [3, 7a, 8b; 7b] From 16 we completed the synthesis of 1, 4 and the other truncated analogues according to procedures of Danishefsky and co-workers. [3] Given the interest in 4 (its reported activity in^^vivo and interest in its mechanism of action), [5] it was prepared in 100^^mg It was previously demonstrated that E-cadherin dynamics assessed by fluorescence recovery after photobleaching (FRAP) can be used as a pharmacodynamic marker both in^^vitro and in^^vivo. [1,^17] Photobleaching is a widely used technique for the study of molecular dynamics within cultured cells. In FRAP analysis, a small region of the sample is bleached with a laser, and recovered fluorescence in the bleached region is assessed over time. [18] Two variables are measured: 1)^^half-time recovery (HTR) and 2)^^immobile fraction (IF). Half-time recovery reflects the rate at which fluorescent molecules move into or out of the bleached region. The immobile fraction indicates how many of the fluorescent molecules remain trapped in the bleached region. This method is useful for evaluating the effects of small molecules on E-cadherin dynamics. <?><?>It was previously demonstrated that Fluorescence Recovery After Photobleaching (FRAP) of E-Cadherin-GFP can be used as a pharmacodynamic marker both in vitro and in vivo.
[1] Serrels et al., Cancer Research 2009 No deleterious effects of E-cadherin--GFP in these cells were observed, and proliferation and cell junction formation appeared normal in the absence of small molecules.
please add reference for this GFP experiment -cite to reference 1); also, "small molecules" have not been mentioned above (either absence or presence) --please clarify (eg. which small molecules) or th ereference to small molecules can be removed<?><?>
Therefore, FRAP was used to assess the effect of 4 on pancreatic ductal adenocarcinoma (PDAC) cells stably expressing E-cadherin--GFP. These cells are highly invasive because of expression of a mutant form of the tumour suppressor p53 [19] and can To assess the effects of macroketone treatment in^^vivo, PDAC cells were injected subcutaneously into the flank of a nude mouse and a tumour was allowed to form. After seven days mice were treated with either vehicle or 20^^mg^kg <M->1^^4 for three consecutive days, and intravital imaging was performed. Consistent with previous observations, we observed different effects on E-cadherin dynamics in^^vitro compared to in^^vivo. 
Conclusions
We describe a new synthetic approach to key intermediate^^16, which is used in the preparation of macroketone^^4, migrastatin^^1 and other truncated migrastatin analogues.
The synthetic route reported herein is competitive with other synthetic procedures. The effect of treatment with 4 on E-cadherin dynamics was studied by using FRAP. for an additional 40^^min, then β-methoxydiisopinocampheylborane (17.09^^g, 54.0^^mmol) in THF (90^^mL) was added dropwise through a cannula. The mixture was stirred at <M->78^°C for 1.5^^h, then boron trifluoride etherate (8.80^^mL, 69.7^^mmol) was added dropwise at <M->78^°C.
Immediately, a solution of aldehyde^^10 (6.60^^g, 34.9^^mmol) in THF (80^^mL) was added, and the mixture was stirred at <M->78^°C for 28^^h. Then aqueous NaOH (1^M, 24.9^^mL) was added followed by H 2 O 2 (30^%, 24.9^^mL), and the biphasic mixture was allowed to equilibrate to room temperature slowly. After stirring for another 16^^h the mixture was diluted with ethyl ether, then the organic layer was separated, washed with saturated aqueous NH 4 Cl and dried over Na 2 SO 4 , and the solvent was removed under reduced pressure. Chromatography of the residue (petroleum ether/EtOAc, 6:1) afforded a mixture of 11 and pinenol (total weight=23.5^^g), which was then used directly in the next step. The mixture containing 11 (23.5^^g) was dissolved in dry methanol (100^^mL), K 2 CO 3 8 (5.50^^g) was added, the mixture was stirred at room temperature for 64^^h, and the solvent was then removed under reduced pressure. 
<+>(2R,3S,4S)-3-(tert-Butyldimethylsilyloxy)-4-methoxy-2-methylhex-5-en-1-ol (13):
Triethylamine (10.7^^mL, 76.9^^mmol) and TBSOTf (14.1^^mL, 61.6^^mmol) were added to a solution of 12 (4.10^^g, 25.6^^mmol) in dichloromethane (270^^mL) at 0^°C. The reaction mixture was stirred at 0^°C for 1.5^^h, quenched with saturated aqueous NH 4 Cl and extracted with dichloromethane (4×100^^mL). The combined organic portion was dried over NaSO 4 , and the solvent was removed under reduced pressure to give (2R,3S,4S)-1,3-di-(tert-butyldimethylsilyloxy)-4-methoxy-2-methylhex-5-en-1-ol. This was dissolved in methanol (270^^mL), then p-TSA (487^^mg, 2.57^^mmol) was added at 0^°C, and the mixture was stirred at room temperature for 2^^h. Triethyl amine (0.35^^mL, 2.55^^mmol) was then added, and the solvent was removed under reduced pressure. The above paragraph could be removed from the paper if it is still confusing.
<+>(2S,3S,4S)-3-(tert-Butyldimethylsilyloxy)-4-methoxy-2-methylhex-5-enal (14):
Pyridine (1.5^mL, 18.7^mmol) and the Dess--Martin reagent (3.18^g, 7.49^mmol) were added to 13
(1.71^g, 6.24^mmol) in dichloromethane (50^mL) at 0^°C. The solution was stirred at room temperature for 16^h, then saturated aqueous Na 2 S 2 O 3 and NaHCO 3 (1:1, 150^mL) were introduced to quench the reaction. After vigorous stirring for 1.5^h, the separated aqueous layer was extracted with CH 2 Cl 2 (3×100^mL). The combined organic portion was then washed with saturated brine, dried, and the solvent was removed under reduced pressure. Chromatography of the residue (petroleum ether/EtOAc, 20:1) gave aldehyde^^14 (1.58^g, 93^%) as a colourless oil. 1 H^^NMR (500^^MHz, The mice were generated in house by crossing multiple pre-existing strains as described in: Morton, J. <+>Cell-derived matrices (CDMs): Cell-derived matrices were grown on glass-bottom dishes as described previously. [22,^23] They were subsequently treated with 10^^μM 4 and analysed by FRAP.
<+>Assessment of E-cadherin dynamics in^^vivo:
Intravital imaging was preformed as described previously. [24] Following trypsinisation, cells 
Figure^^2
Influence of macroketone^^4 on fluorescence recovery after photobleaching (FRAP) of E-cadherin--GFP in PDAC cells on a cell-derived matrix (CDM) and in^^vivo.
A)^^PDAC cells stably expressing E-cadherin--GFP were seeded onto matrices and treated with 10^^μM^^4 2^^h prior to FRAP imaging. B)^^PDAC cells stably expressing E-cadherin--GFP were injected subcutaneously into nude mice, and tumours were allowed to form for 
